Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Viracta Therapeutics Has Received A Notice Of Allowance For Its U.S. Patent Application 18/240,853 titled "HDAC INHIBITOR SOLID STATE FORMS (FOR THE TREATMENT OF CANCER, IMMUNE DISORDERS, AND INFLAMMATION)"

Author: Benzinga Newsdesk | August 09, 2024 01:21pm

Posted In: VIRX